## CL: Colgate-Palmolive Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -5.5% below STRENGTH zone (4.0-10.0%); PEG 1.60 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($73.31)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Colgate-Palmolive Company $CL Shares Purchased by Epoch Investment Partners Inc.**
- Source: MarketBeat | 20251206T095414 | Somewhat-Bullish | Relevance: 99%
-  Epoch Investment Partners Inc. significantly increased its stake in Colgate-Palmolive (NYSE:CL) during Q2 2025, now holding shares valued at over $15 million. Institutional investors collectively own over 80% of the company's stock. Analysts generally maintain a "Moderate Buy" rating for CL, with some recent price target adjustments.

**2. ধারাবাহিক বিনিয়োগকারীদের মনোযোগ আকর্ষণ করছে**
- Source: MarketBeat | 20251208T085229 | Neutral | Relevance: 99%
-  Edgestream Partners L.P. significantly reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 78.9% in the second quarter, selling 15,614 shares and retaining 4,175 shares valued at approximately $380,000. Despite this, institutional investors collectively hold about 80.41% of the company's stock. Colgate-Palmolive reported strong quarterly earnings of $0.91 EPS, beating estimates, and maintains a "Moderate Buy" consensus analyst rating with an average price target of $89.87.

**3. Colgate-Palmolive shares rise as RBC upgrades to 'outperform'**
- Source: TradingView | 20251209T093827 | Bullish | Relevance: 99%
-  Shares of Colgate-Palmolive rose nearly 1% after RBC Capital Markets upgraded the stock rating to "outperform" from "sector perform." RBC cited low current expectations and a favorable setup for the company to return to long-term growth, despite a challenging global environment for consumer staples. The brokerage noted Colgate-Palmolive's resilience, delivering 24 straight quarters of organic sales growth at or above their long-term algorithm.

**4. RBC Capital upgrades Colgate-Palmolive stock to Outperform on favorable setup**
- Source: Investing.com | 20251209T085103 | Bullish | Relevance: 98%
-  RBC Capital has upgraded Colgate-Palmolive (NYSE:CL) from Sector Perform to Outperform, maintaining an $88.00 price target, signaling significant upside potential as the stock is considered undervalued. The upgrade follows pressure on shares due to slowing global category growth, and the firm believes expectations have been appropriately lowered, setting up a favorable return to long-term growth. Colgate-Palmolive recently reported increased net sales and EPS for Q2 2025, confirming guidance for low single-digit EPS growth for the year.

**5. 2 Safe-and-Steady Stocks with Competitive Advantages and 1 We Find Risky**
- Source: Finviz | 20251208T233700 | Bullish | Relevance: 98%
-  This article identifies two low-volatility stocks, Colgate-Palmolive (CL) and HNI (HNI), offering safe-and-steady growth due to competitive advantages such as strong brand recognition, pricing power, and efficient operations. Conversely, it cautions against Old Republic International (ORI) due to concerns about sluggish premium growth, underperforming earnings, and forecasted book value decline. The piece uses StockStory's analysis to guide investors on navigating low-volatility options.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($0.07M) |
| Sells | 23 ($1.66M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.3% (+0.2%)
- Blackrock Inc.: 8.6% (+0.5%)
- State Street Corpora: 6.0% (+0.2%)
- Price (T.Rowe) Assoc: 4.0% (-11.5%)
- Geode Capital Manage: 2.7% (+4.1%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.7% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 11.8% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.60 elevated, pricing in significant growth expectations. Forward P/E 19.8x stretched relative to 5% growth. Quality metrics strong (ROE 294%, ROA 15%). Balance sheet: $1.1B free cash flow. Insider selling cluster ($1.7M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $61.5B |
| Beta | 0.29 |
| 52W Range | $74.55 - $100.18 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.60 |
| Forward P/E | 19.8 |
| Current P/E | 20.8 |
| YoY Growth | 5.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -1.8% to -5.5% (-3.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.5pp (needs >4.0% for momentum thesis). AM_20 at -3.5% indicates price below own 20MA trend. Underperforming sector by 3.5pp, stock-specific weakness. Below SMA200 (0.88x), long-term trend not supportive.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.51% (CS: 11) | Weak |
| RSI_14 | 38.7 | Neutral |
| MACD Histogram | -0.30 | Bearish |
| vs SMA20 | 0.965x | Below |
| vs SMA50 | 0.972x | Below |
| vs SMA200 | 0.882x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $76.11
- **Stop Loss:** $73.31 (3.7% risk)
- **Target:** $78.91 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 178
- **Position Value:** $13,547.58
- **Portfolio %:** 13.55%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-01-30 (Est: $0.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.89 | $0.91 | +2.4% |
| 2025Q2 | $0.89 | $0.92 | +2.8% |
| 2025Q1 | $0.86 | $0.91 | +6.1% |
| 2024Q4 | $0.89 | $0.91 | +2.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*